Authors:
SCHMIEGELOW ML
SOMMER P
CARLSEN E
SONKSEN JOR
SCHMIEGELOW K
MULLER JR
Citation: Ml. Schmiegelow et al., PENILE VIBRATORY STIMULATION AND ELECTROEJACULATION BEFORE ANTICANCERTHERAPY IN 2 PUBERTAL BOYS, Journal of pediatric hematology/oncology, 20(5), 1998, pp. 429-430
Citation: K. Schmiegelow, MAINTENANCE CHEMOTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN - CLINICAL AND PHARMACOLOGICAL ASPECTS OF THE MONITORING AND ADJUSTMENT OF ORAL METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE, Danish medical bulletin, 45(5), 1998, pp. 510-532
Authors:
PIETERS R
DENBOER ML
DURIAN M
JANKA G
SCHMIEGELOW K
KASPERS GJL
VANWERING ER
VEERMAN AJP
Citation: R. Pieters et al., RELATION BETWEEN AGE, IMMUNOPHENOTYPE AND IN-VITRO DRUG-RESISTANCE IN395 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT OF INFANTS, Leukemia, 12(9), 1998, pp. 1344-1348
Authors:
ANDERSEN JB
SZUMLANSKI C
WEINSHILBOUM RM
SCHMIEGELOW K
Citation: Jb. Andersen et al., PHARMACOKINETICS, DOSE ADJUSTMENTS, AND 6-MERCAPTOPURINE METHOTREXATEDRUG-INTERACTIONS IN 2 PATIENTS WITH THIOPURINE METHYLTRANSFERASE DEFICIENCY/, Acta paediatrica, 87(1), 1998, pp. 108-111
Authors:
HOFFMANN T
HEILMANN C
MADSEN HO
VINDELOV L
SCHMIEGELOW K
Citation: T. Hoffmann et al., MATCHED UNRELATED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENT MALIGNANT-LYMPHOMA IN A PATIENT WITH X-LINKED LYMPHOPROLIFERATIVE DISEASE (XLP), Bone marrow transplantation, 22(6), 1998, pp. 603-604
Authors:
KASPERS GJL
NYVOLD C
PIETERS R
ROTTIER MMA
KNABE N
MADSEN HO
RYDER LP
SCHMIEGELOW K
Citation: Gjl. Kaspers et al., IN-VITRO RESISTANCE TO PREDNISOLONE IS RELATED TO MINIMAL RESIDUAL DISEASE AT DAY-29 OF INDUCTION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 231-231
Authors:
RAMAKERSVANWOERDEN NL
PIETERS R
KAZEMIER KM
VANDRUNEN E
HARBOTT J
SEYFERT J
BEVERLOO HB
SLATER R
VANWERING ER
LUDWIG WD
JANKASCHAUB G
SCHMIEGELOW K
VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., TEL AML1 GENE FUSION IS NOT ASSOCIATED WITH IN-VITRO DRUG-SENSITIVITYIN ACUTE LYMPHOBLASTIC VITRO DRUG LEUKEMIA/, British Journal of Haematology, 102(1), 1998, pp. 231-231
Authors:
RAMAKERSVANWOERDEN NL
PIETERS R
BEVERLOO HB
LOONEN AH
SLATER R
VANWERING ER
LUDWIG WD
HARBOTT J
JANKASCHAUB G
SCHMIEGELOW K
VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., IN-VITRO DRUG-RESISTANCE PROFILE IN MLL-GENE REARRANGED INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 232-232
Authors:
SCHMIEGELOW K
GLOMSTEIN A
KRISTINSSON J
SALMI T
SCHRODER H
BJORK O
Citation: K. Schmiegelow et al., IMPACT OF MORNING VERSUS EVENING SCHEDULE FOR ORAL METHOTREXATE AND 6-MERCAPTOPURINE ON RELAPSE RISK FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of pediatric hematology/oncology, 19(2), 1997, pp. 102-109
Authors:
OTTERNESS D
SZUMLANSKI C
LENNARD L
KLEMETSDAL B
AARBAKKE J
PARKHAH JO
IVEN H
SCHMIEGELOW K
BRANUM E
OBRIEN J
WEINSHILBOUM R
Citation: D. Otterness et al., HUMAN THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - GENE SEQUENCE POLYMORPHISMS, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 60-73
Authors:
IVERSEN PO
LEWIS ID
TURCZYNOWICZ S
HASLE H
NIEMEYER C
SCHMIEGELOW K
BASTIRAS S
BIONDI A
HUGHES TP
LOPEZ AF
Citation: Po. Iversen et al., INHIBITION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PREVENTS DISSEMINATION AND INDUCES REMISSION OF JUVENILE MYELOMONOCYTIC LEUKEMIA IN ENGRAFTED IMMUNODEFICIENT MICE, Blood, 90(12), 1997, pp. 4910-4917
Citation: K. Schmiegelow et M. Ifversen, MYELOTOXICITY, PHARMACOKINETICS, AND RELAPSE RATE WITH METHOTREXATE 6-MERCAPTOPURINE MAINTENANCE THERAPY OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA/, Pediatric hematology and oncology, 13(5), 1996, pp. 433-441
Citation: A. Poulsen et al., VARICELLA-ZOSTER INFECTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Pediatric hematology and oncology, 13(3), 1996, pp. 231-238
Authors:
GROSS TG
FILIPOVICH AH
CONLEY ME
PRACHER E
SCHMIEGELOW K
VERDIRAME JD
VOWELS M
WILLIAMS LL
SEEMAYER TA
Citation: Tg. Gross et al., CURE OF X-LINKED LYMPHOPROLIFERATIVE DISEASE (XLP) WITH ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - REPORT FROM THE XLP REGISTRY, Bone marrow transplantation, 17(5), 1996, pp. 741-744
Authors:
MARKY I
SCHMIEGELOW K
PERKKIO M
JONSSON OG
STORMMATHIESEN I
GUSTAFSSON G
KREUGER A
LANGMARK F
Citation: I. Marky et al., CHILDHOOD NON-HODGKINS-LYMPHOMA IN THE 5 NORDIC COUNTRIES - A 5-YEAR POPULATION-BASED STUDY FROM THE NORDIC SOCIETY OF PEDIATRIC HEMATOLOGYAND ONCOLOGY, Journal of pediatric hematology/oncology, 17(2), 1995, pp. 163-166
Authors:
SCHMIEGELOW K
SCHRODER H
GUSTAFSSON G
KRISTINSSON J
GLOMSTEIN A
SALMI T
WRANNE L
Citation: K. Schmiegelow et al., RISK OF RELAPSE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IS RELATED TO RBC METHOTREXATE AND MERCAPTOPURINE METABOLITES DURING MAINTENANCE CHEMOTHERAPY, Journal of clinical oncology, 13(2), 1995, pp. 345-351
Authors:
NERSTROM VM
HENRIKSEN U
NIELSEN PE
BUCHARDT O
SCHMIEGELOW K
KOCH C
Citation: Vm. Nerstrom et al., MONOCLONAL-ANTIBODIES TO THIOGUANINE - INFLUENCE OF COUPLING POSITIONON FINE SPECIFICITY, Bioconjugate chemistry, 5(4), 1994, pp. 357-363
Citation: K. Schmiegelow et al., METHOTREXATE AND 6-MERCAPTOPURINE MAINTENANCE THERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - DOSE ADJUSTMENTS BY WHITE CELL COUNTS ORBY PHARMACOKINETIC PARAMETERS, Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 209-215
Authors:
NIELSEN FC
ORSKOV C
HASELBACHER G
RAMLAU J
CHRISTIANSEN J
SCHMIEGELOW K
REHFELD JF
Citation: Fc. Nielsen et al., INSULIN-LIKE GROWTH-FACTOR-II MESSENGER-RNA, PEPTIDES, AND RECEPTORS IN A THORACOPULMONARY MALIGNANT SMALL ROUND-CELL TURNER, Cancer, 73(4), 1994, pp. 1312-1319